Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanni Wang

Showing results (181-190 of 194) with videos related to

Pageof 20
Sort By:
Frontiers in Immunology|September 26, 2022
Serological biomarkers predict immune-related adverse events and clinical benefit in patients with advanced gastrointestinal cancersYanni Wang, Jianling Zou, Yun Li, et al.
Cancer Biology & Medicine|September 27, 2021
Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancerYujiao Wang, Xi Jiao, Shuang Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2013
Characterization of pathogenic human monoclonal autoantibodies against GM-CSFYanni Wang, Christy A Thomson, Lenka L Allan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2025
<i>NOTCH1</i> Mutation and Survival Analysis of Tislelizumab in Advanced or Metastatic Esophageal Squamous Cell Carcinoma: A Biomarker Analysis From the Randomized, Phase III, RATIONALE-302 TrialZhihao Lu, Wenting Du, Xi Jiao, et al.
Signal Transduction and Targeted Therapy|June 27, 2024
Clinical efficacy and identification of factors confer resistance to afatinib (tyrosine kinase inhibitor) in EGFR-overexpressing esophageal squamous cell carcinomaYanni Wang, Chang Liu, Huan Chen, et al.
Oncotarget|October 27, 2017
Determination of <i>IL-1B</i> (rs16944) and <i>IL-6</i> (rs1800796) genetic polymorphisms in IgA nephropathy in a northwest Chinese Han populationDaofa Zhang, Maowei Xie, Xiaohong Yang, et al.
National Science Review|December 23, 2024
Discovery of natural few-layer graphene on the MoonWei Zhang, Qing Liang, Xiujuan Li, et al.
JAMA|August 25, 2025
A Fall Prevention Program Integrated in Primary Health Care for Older People in Rural China: The FAMILY Cluster Randomized Clinical TrialJunyi Peng, Pengpeng Ye, Boya Nan, et al.
Cancer Immunology, Immunotherapy : CII|February 25, 2025
An integrated prognosis prediction model based on real-word clinical characteristics for immunotherapy in advanced esophageal squamous cell carcinomaLiyuan Dong, Yue Ma, Guang Cao, et al.
Cancer Immunology, Immunotherapy : CII|May 24, 2021
PTCH1 mutation promotes antitumor immunity and the response to immune checkpoint inhibitors in colorectal cancer patientsYanni Wang, Huan Chen, Xi Jiao, et al.
Pageof 20

Showing results (181-190 of 194) with videos related to

Sort By:
Pageof 20
Frontiers in Immunology|September 26, 2022
Serological biomarkers predict immune-related adverse events and clinical benefit in patients with advanced gastrointestinal cancersYanni Wang, Jianling Zou, Yun Li, et al.
Cancer Biology & Medicine|September 27, 2021
Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancerYujiao Wang, Xi Jiao, Shuang Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 27, 2013
Characterization of pathogenic human monoclonal autoantibodies against GM-CSFYanni Wang, Christy A Thomson, Lenka L Allan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2025
<i>NOTCH1</i> Mutation and Survival Analysis of Tislelizumab in Advanced or Metastatic Esophageal Squamous Cell Carcinoma: A Biomarker Analysis From the Randomized, Phase III, RATIONALE-302 TrialZhihao Lu, Wenting Du, Xi Jiao, et al.
Signal Transduction and Targeted Therapy|June 27, 2024
Clinical efficacy and identification of factors confer resistance to afatinib (tyrosine kinase inhibitor) in EGFR-overexpressing esophageal squamous cell carcinomaYanni Wang, Chang Liu, Huan Chen, et al.
Oncotarget|October 27, 2017
Determination of <i>IL-1B</i> (rs16944) and <i>IL-6</i> (rs1800796) genetic polymorphisms in IgA nephropathy in a northwest Chinese Han populationDaofa Zhang, Maowei Xie, Xiaohong Yang, et al.
National Science Review|December 23, 2024
Discovery of natural few-layer graphene on the MoonWei Zhang, Qing Liang, Xiujuan Li, et al.
JAMA|August 25, 2025
A Fall Prevention Program Integrated in Primary Health Care for Older People in Rural China: The FAMILY Cluster Randomized Clinical TrialJunyi Peng, Pengpeng Ye, Boya Nan, et al.
Cancer Immunology, Immunotherapy : CII|February 25, 2025
An integrated prognosis prediction model based on real-word clinical characteristics for immunotherapy in advanced esophageal squamous cell carcinomaLiyuan Dong, Yue Ma, Guang Cao, et al.
Cancer Immunology, Immunotherapy : CII|May 24, 2021
PTCH1 mutation promotes antitumor immunity and the response to immune checkpoint inhibitors in colorectal cancer patientsYanni Wang, Huan Chen, Xi Jiao, et al.
Pageof 20